Bailard, Inc. Vbi Vaccines Inc Transaction History

Bailard, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.8 - $3.72 $210,000 - $279,000	-75,000 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$2.15 - $3.5 $437,740 - $712,600	-203,600 Reduced 73.08%	75,000 $206,000
Q3 2020 Nov 10, 2020	BUY	$2.77 - $6.17 $771,722 - $1.72 Million	278,600 New	278,600 $797,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.